Tumor pO2 as a Surrogate Marker to Identify Therapeutic Window During Metronomic Chemotherapy of 9L Gliomas
Advances in Experimental Medicine and Biology - United States
doi 10.1007/978-1-4419-7756-4_15
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Springer US